Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-23

I was going to give this post a C+ as it appeared to actually talk about the stock. But then it descended into a rage post on some other stock, so I'll give it a C-. But keep trying mate, you'll get there!

It did encourage to me look up when Norwood received their R&D last year, was in just the last quarter (March 24), year before was December 22. So Norwood bringing this forward certainly adds to the stench of desperation the company finds itself in.

And yes, the company will be borrowing more money, it will draw down on its Radium loan.

The just announced quarterly expenses were $704k. So deducting that from the $69+254+349 leaves them $32k in deficit by September 30. You'd want to hope they have a little more revenue then the $254k already paid to balance that book.

And then what? They are broke again with no R&D, just the R&D loan... CRs aren't a matter of if, but when. And of minor interest is who. Sales on the other hand are a big big if.